PMC:7268883 / 19361-19983 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"363","span":{"begin":525,"end":537},"obj":"Species"},{"id":"364","span":{"begin":573,"end":585},"obj":"Species"},{"id":"365","span":{"begin":413,"end":432},"obj":"Disease"}],"attributes":[{"id":"A363","pred":"tao:has_database_id","subj":"363","obj":"Tax:9606"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"Tax:9606"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:D010182"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T175","span":{"begin":413,"end":432},"obj":"Disease"}],"attributes":[{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0002356"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T62","span":{"begin":103,"end":104},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T63","span":{"begin":442,"end":443},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T64","span":{"begin":559,"end":560},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":461,"end":466},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-sentences","denotations":[{"id":"T124","span":{"begin":0,"end":25},"obj":"Sentence"},{"id":"T125","span":{"begin":26,"end":144},"obj":"Sentence"},{"id":"T126","span":{"begin":145,"end":217},"obj":"Sentence"},{"id":"T127","span":{"begin":218,"end":433},"obj":"Sentence"},{"id":"T128","span":{"begin":434,"end":546},"obj":"Sentence"},{"id":"T129","span":{"begin":547,"end":622},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":413,"end":432},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0001732"}],"text":"Strengths and Limitations\nThe strength of this survey is the global range of respondents, representing a wide range of countries and continents. However, the results should be interpreted in light of some limitations. First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases. Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%). Third, only a minority of participants represented the nonacademic centers."}